|
|
||||||||
Department of Internal Medicine, Division of Nuclear Medicine, and Departments of Physiology and Surgery, University of Michigan Medical Center, Ann Arbor, Michigan
Correspondence: For reprints contact: Markus Schwaiger, MD, University of Michigan Hospital, 1500 Medical Center Dr, UH B1 G505, Box 0028, Ann Arbor, MI 48109.
ABSTRACT
The relationship between myocardial blood flow as a marker of severity of ischemia and exogenous glucose utilization was examined following occlusion of the left anterior descending coronary artery in 10 fasted, anesthetized, open-chest dogs. Fluorine-18-fluorodeoxyglucose (FDG) was injected 10 min after the onset of ischemia and serial blood samples were obtained to measure FDG in plasma. Tracer-labeled microspheres, used to measure myocardial blood flow (MBF), were injected 10 and 40 min postocclusion. After the last microsphere injection, the heart was arrested and removed rapidly. Tissue samples of the left ventricle were obtained, weighed and FDG counts were determined. Two days later, the same samples were assayed for radioactivity from the tracer-labeled microspheres and blood flow was calculated. Thus, FDG uptake and MBF measurements were made in the same tissue samples. When normalized for variations in blood flow, there were no significant differences in FDG uptake between the subendocardial and subepicardial halves of the tissue samples. FDG uptake was relatively high and uniform in normal myocardium, paralleling the pattern of MBF. In ischemic myocardium, however, FDG uptake and MBF did not vary in parallel. In tissue samples with MBF reduced by up to 80% from control levels, relative FDG uptake increased such that absolute FDG uptake remained at normal or near normal levels. In samples with more severe ischemia, FDG uptake decreased precipitously with additional decrements in MBF. We propose that sufficient glycolytic flux may be sustained to maintain cellular viability when perfusion is above the threshold value. Below the threshold, however, irreversible changes maybe initiated.
This article has been cited by other articles:
![]() |
C. Q. Shi, L. H. Young, E. Daher, E. V.R. DiBella, Y.-H. Liu, E. N. Heller, S. Zoghbi, F. J.Th. Wackers, R. Soufer, and A. J. Sinusas Correlation of Myocardial p-123I-Iodophenylpentadecanoic Acid Retention with 18F-FDG Accumulation During Experimental Low-Flow Ischemia J. Nucl. Med., March 1, 2002; 43(3): 421 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Haas, N. Augustin, K. Holper, M. Wottke, C. Haehnel, S. Nekolla, H. Meisner, R.u. Lange, and M. Schwaiger Time course and extent of improvement of dysfunctioning myocardium in patients with coronary artery disease and severely depressed left ventricular function after revascularization: correlation with positron emission tomographic findings J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1927 - 1934. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Fallavollita Spatial Heterogeneity in Fasting and Insulin-Stimulated 18F-2-Deoxyglucose Uptake in Pigs With Hibernating Myocardium Circulation, August 22, 2000; 102(8): 908 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Fallavollita, C. Trojan, and J. M. Canty Jr. Transmural distribution of FDG uptake in stunned myocardium Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H102 - H109. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jadvar, H. W. Strauss, and G. M. Segall SPECT and PET in the Evaluation of Coronary Artery Disease RadioGraphics, July 1, 1999; 19(4): 915 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Fallavollita and J. M. Canty Jr Differential 18F-2-Deoxyglucose Uptake in Viable Dysfunctional Myocardium With Normal Resting Perfusion : Evidence for Chronic Stunning in Pigs Circulation, June 1, 1999; 99(21): 2798 - 2805. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M King and L. H Opie Glucose delivery is a major determinant of glucose utilisation in the ischemic myocardium with a residual coronary flow Cardiovasc Res, August 1, 1998; 39(2): 381 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Egert, N. Nguyen, F. C Brosius III, and M. Schwaiger Effects of wortmannin on insulin- and ischemia-induced stimulation of GLUT4 translocation and FDG uptake in perfused rat hearts Cardiovasc Res, August 1, 1997; 35(2): 283 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Fallavollita, B. J. Perry, and J. M. Canty Jr 18F-2-Deoxyglucose Deposition and Regional Flow in Pigs With Chronically Dysfunctional Myocardium : Evidence for Transmural Variations in Chronic Hibernating Myocardium Circulation, April 1, 1997; 95(7): 1900 - 1909. [Abstract] [Full Text] |
||||
![]() |
M. Maki, M. Luotolahti, P. Nuutila, H. Iida, L.-M. Voipio-Pulkki, U. Ruotsalainen, M. Haaparanta, O. Solin, J. Hartiala, R. Harkonen, et al. Glucose Uptake in the Chronically Dysfunctional but Viable Myocardium Circulation, May 1, 1996; 93(9): 1658 - 1666. [Abstract] [Full Text] |
||||
![]() |
N. Tamaki, M. Kawamoto, E. Tadamura, Y. Magata, Y. Yonekura, R. Nohara, S. Sasayama, K. Nishimura, T. Ban, and J. Konishi Prediction of ReversibleIschemia After Revascularization : Perfusion and Metabolic Studies WithPositron Emission Tomography Circulation, March 15, 1995; 91(6): 1697 - 1705. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |